Search

everythinglearnresearchcommunity

for

Search:↓

Herbal nano-formulations show potential for effective skin delivery but need more research.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Mutations in mitochondrial DNA might significantly contribute to the development of Polycystic Ovarian Syndrome.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

Skin health and diseases are closely linked to metabolic processes.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Certain gene variations increase the risk of alopecia areata in Koreans.

UV exposure reduces Lgr6+ stem cells in mouse skin and they don't significantly contribute to skin cancer development.

The document concludes that stem cells and their environments are crucial for skin and hair health and have potential for medical treatments.

The journal covered various dermatology topics, including treatments, disease management, and research findings.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Dermoscopy has improved skin cancer diagnosis and has expanding applications in dermatology, but requires staying updated with new research and techniques.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

A man developed skin cancer on his scalp after multiple artificial hair grafts.

Spironolactone does not increase the risk of breast cancer recurrence.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

The book gives a basic overview of mesotherapy and fat-dissolving injections but lacks detailed guidance and effectiveness comparisons for practitioners.

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Melatonin is important for skin health and protection, and can be made by the skin or applied to it.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.